Immunocore Holdings plc - ADR (IMCR)

CUSIP: 45258D105

Q3 2024 13F Holders as of 30 Sep 2024

Type / Class
Equity / ADR
Shares outstanding
50,698,400
Total 13F shares
45,295,985
Share change
+2,218,230
Total reported value
$1,411,075,539
Put/Call ratio
234%
Price per share
$31.13
Number of holders
129
Value change
+$61,107,953
Number of buys
63
Number of sells
63

Quarterly Holders Quick Answers

What is CUSIP 45258D105?
CUSIP 45258D105 identifies IMCR - Immunocore Holdings plc - ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMCR - Immunocore Holdings plc - ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13%
6,380,451
$216,233,483 30 Jun 2024
13F
RTW INVESTMENTS, LP
13F
Company
9.6%
4,869,798
$165,037,454 30 Jun 2024
13F
FMR LLC
13F
Company
9.5%
4,812,604
$163,099,159 30 Jun 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
5.9%
2,992,273
$101,409,000 30 Jun 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
5.6%
2,832,669
$96,000,000 30 Jun 2024
13F
PRIMECAP MANAGEMENT CO/CA/
13F
Company
3.8%
1,951,070
$66,121,762 30 Jun 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
3%
1,515,318
$51,354,127 30 Jun 2024
13F
GENERAL ATLANTIC, L.P.
13F
Individual
2.5%
1,261,684
$42,758,471 30 Jun 2024
13F
Bellevue Group AG
13F
Company
2.3%
1,154,654
$39,131,224 30 Jun 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
1.9%
976,000
$33,076,640 30 Jun 2024
13F
Fiera Capital Corp
13F
Company
1.7%
875,593
$29,673,847 30 Jun 2024
13F
BlackRock Finance, Inc.
13F
Company
1.7%
871,793
$29,545,065 30 Jun 2024
13F
MORGAN STANLEY
13F
Company
1.7%
868,864
$29,445,835 30 Jun 2024
13F
BRAIDWELL LP
13F
Company
1.6%
797,268
$27,019,413 30 Jun 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.3%
646,920
$21,924,119 30 Jun 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.2%
600,954
$20,366,331 30 Jun 2024
13F
Polar Capital Holdings Plc
13F
Company
0.99%
502,570
$17,032,097 30 Jun 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.9%
457,500
$15,504,675 30 Jun 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.87%
439,453
$14,893,062 30 Jun 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.86%
437,112
$14,813,778 30 Jun 2024
13F
Rock Springs Capital Management LP
13F
Company
0.83%
419,030
$14,200,927 30 Jun 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.8%
405,600
$13,745,784 30 Jun 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.78%
397,463
$13,470,000 30 Jun 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.77%
390,565
$13,236,248 30 Jun 2024
13F
STEMPOINT CAPITAL LP
13F
Company
0.67%
339,351
$11,500,605 30 Jun 2024
13F
S.c.a. Candriam
13F
Individual
0.62%
313,423
$10,621,410 30 Jun 2024
13F
LOOMIS SAYLES & CO L P
13F
Company
0.6%
301,815
$10,228,000 30 Jun 2024
13F
First Turn Management, LLC
13F
Company
0.57%
291,086
$9,864,905 30 Jun 2024
13F
Woodline Partners LP
13F
Company
0.54%
274,038
$9,287,148 30 Jun 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.52%
264,896
$8,977,325 30 Jun 2024
13F
CANTOR FITZGERALD, L. P.
13F
Individual
0.5%
254,027
$8,608,975 30 Jun 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.5%
251,819
$8,534,146 30 Jun 2024
13F
MARSHALL WACE, LLP
13F
Company
0.49%
248,654
$8,426,883 30 Jun 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.46%
232,594
$7,882,611 30 Jun 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.45%
228,952
$7,759,183 30 Jun 2024
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.4%
205,243
$6,956,000 30 Jun 2024
13F
Avidity Partners Management LP
13F
Company
0.39%
200,000
$6,778,000 30 Jun 2024
13F
Hudson Bay Capital Management LP
13F
Company
0.38%
193,179
$6,546,836 30 Jun 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.35%
175,668
$5,953,382 30 Jun 2024
13F
SG Americas Securities, LLC
13F
Company
0.32%
160,358
$5,435,000 30 Jun 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.26%
132,613
$4,494,254 30 Jun 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.24%
121,753
$4,126,209 30 Jun 2024
13F
Legal & General Group Plc
13F
Company
0.24%
120,517
$4,084,321 30 Jun 2024
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
0.2%
101,964
$3,714,548 30 Jun 2024
13F
Frazier Life Sciences Management, L.P.
13F
Company
0.21%
108,762
$3,685,944 30 Jun 2024
13F
AXA S.A.
13F
Company
0.19%
95,012
$3,219,957 30 Jun 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.18%
90,184
$3,056,336 30 Jun 2024
13F
Walleye Capital LLC
13F
Company
0.18%
89,208
$3,023,259 30 Jun 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.16%
81,782
$2,771,592 30 Jun 2024
13F
Pier Capital, LLC
13F
Company
0.16%
81,306
$2,755,460 30 Jun 2024
13F

Institutional Holders of Immunocore Holdings plc - ADR (IMCR) as of Q3 2024

As of 30 Sep 2024, Immunocore Holdings plc - ADR (IMCR) was held by 129 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 45,295,985 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, T. Rowe Price Investment Management, Inc., RTW INVESTMENTS, LP, FMR LLC, PRIMECAP MANAGEMENT CO/CA/, PRICE T ROWE ASSOCIATES INC /MD/, BAKER BROS. ADVISORS LP, ARMISTICE CAPITAL, LLC, GENERAL ATLANTIC, L.P., and Bellevue Group AG. This page lists 130 institutional shareholders reporting positions in this security for the Q3 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2024 vs Q2 2024 Across Filers

Q2 2024 holders
135
Q3 2024 holders
129
Holder diff
-6
Investor Q2 2024 Shares Q3 2024 Shares Share Diff Share Chg % Q2 2024 Value $ Q3 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .